Barriers to prevention of cardiovascular disease in primary care settings in Argentina

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 33, Issue 4, 2013, Pages 259-266

  Ferrante, Daniel ^a   Konfino, Jonatan ^a   Linetzky, Bruno ^a   Tambussi, Ana ^a   Laspiur, Sebástian ^a  

^a Ministerio de Salud ^*  (Argentina)

Author keywords

Argentina; Cardiovascular diseases; Disease prevention; Primary prevention

Indexed keywords

CARDIOVASCULAR DISEASE; DECISION MAKING; DIABETES; DISEASE CONTROL; HEALTH WORKER; PRIMARY HEALTH CARE; RISK FACTOR; SMOKING; WORLD HEALTH ORGANIZATION;

ARGENTINA; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK ASSESSMENT;

ARGENTINA; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK ASSESSMENT;

ARGENTINA;

EID: 84878609787     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892013000400004     Document Type: Article

References (29)

1. World Health Statistics 2011. Geneva: WHO; 2011.
2. Ministerio de Salud. Agrupamiento de causas de mortalidad por division politico territorial de residencia, edad y sexo: Argentina año 2009. Buenos Aires: Ministerio de Salud; 2009. Available from: http://www.deis.gov. ar/publicaciones/archivos/Boletin131.pdf Accessed 1 August 2011.
3. Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011;1:CD004816.
4. Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-81.
5. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849-60.
6. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database Syst Rev. 2009;3:CD001841.
7. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27(5):335-71.
8. Esposti LD, Saragoni S, Benemei S, Battachi P, Geppetti P, Di Bari M, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011;3:47-54.
9. Lopez-Carmona D, Bernal-Lopez M, Mancera-Romero J, Jansen-Chaparro S, Portales-Fernandez I, Baca-Osorio AJ, et al. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP). Eur J Prev Cardiol. 2012;19(5): 1074-81.
10. Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm. 2008;14(3):271-80.
11. Silva H, Hernandez-Hernandez R, Vinueza R, Velasco M, Boissonnet CP, Escobedo J, et al. Cardiovascular risk awareness, treatment, and control in urban Latin America. Am J Ther. 2010;17(2):159-66.
12. Second National Risk Factor Survey. Ministry of Health, Buenos Aires, Argentina. Available from: http://www.msal.gov.ar/ent/images/stories/vigilancia/ pdf/fr-encuesta-nacionalfactores-riesgo-2011.pdf Accessed 11 March 2012.
13. Rey R, Oberti P, Costa H, Picarel A, Marconcini G, Mulaci A, et al. Cumplimiento de metas en prevención primaria y secundaria en Argentina. Análisis del estudio OFFICE. Rev Argent Cardiol. 2004;72(supl 3).
14. Gravel K, Légaré F, Graham ID. Barriers and facilitators to implementing shared decisionmaking in clinical practice: a systematic review of health professionals' perceptions. Implement Sci. 2006;1(16):1-12.
15. Hobbs FDR, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19:596-604.
16. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499-510.
17. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J, et al. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev. 2009;3:CD001096.
18. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;2: CD000409.
19. Jamtvedt G, Young JM, Kristoffersen DT, Thomson O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2003;3:CD000259.
20. Shaw B, Cheater F, Baker R, Gillies C, Hearnshaw H, Flottorp S, et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2005;3:CD005470.
21. World Health Organization. Prevention of cardiovascular disease: pocket guidelines for assessment and management of CVD risk. Geneva: WHO; 2007.
22. Quinn Patton M. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks, California: Sage Publications; 2002.
23. Oktay J. Grounded theory. Oxford: Oxford University Press; 2012.
24. Oppermann M. Triangulation: a methodological discussion. Int J Tourism Res. 2000;2(2):141-6.
25. Conde F, Pérez Andrés C. La investigación cualitativa en salud pública. Rev Esp Salud Pública. 1995;69:145-9.
26. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2-4.
27. Ministerio de Salud de la Nación. Encuesta Nacional de Factores de Riesgo 2005. Buenos Aires: Ministerio de Salud de la Nación; 2005. Available from: http://www.msal.gov.ar/ent Accessed 30 September 2012.
28. Sposito AC, Ramires JA, Jukema JW, Molina JC, da Silva PM, Ghadanfar MM, et al. Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. Curr Med Res Opin. 2009;25(5):1171-8.
29. Légaré F, Ratté S, Gravel K, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions. Patient Educ Couns. 2008;73(3):526-35.